201 related articles for article (PubMed ID: 16868773)
1. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of placenta growth factor in human middle ear cholesteatoma.
Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
5. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
[TBL] [Abstract][Full Text] [Related]
6. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer.
Cheng WL; Wang CS; Huang YH; Liang Y; Lin PY; Hsueh C; Wu YC; Chen WJ; Yu CJ; Lin SR; Lin KH
Int J Cancer; 2008 Oct; 123(8):1787-96. PubMed ID: 18688858
[TBL] [Abstract][Full Text] [Related]
8. Expressions of caspase-14 in human middle ear cholesteatoma.
Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
[TBL] [Abstract][Full Text] [Related]
9. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
11. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
12. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
[No Abstract] [Full Text] [Related]
13. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
Jana NK; Gray LR; Shugars DC
J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
[TBL] [Abstract][Full Text] [Related]
15. [Expression of secretory leukocyte proteinase inhibitor in human bronchial epithelial cell is downregulated by transforming growth factor-beta1/Smads pathway].
Niu RC; Luo BL; Hu CP; Feng JT
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2117-21. PubMed ID: 19080472
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expressions of lysozyme, SLPI and glycoprotein 340 in biofilm-associated chronic rhinosinusitis.
Dong D; Yulin Z; Yan X; Hongyan Z; Shitao Z; Jia W
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1563-71. PubMed ID: 24121782
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
Park M; Lee B; Lee J
ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
[TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells.
Zuo J; Zhang C; Ren C; Pang D; Li Y; Xie X; Tang Z; Jiang X
Clin Transl Oncol; 2015 Apr; 17(4):314-21. PubMed ID: 25319722
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa.
Wex T; Mönkemüller K; Kuester D; Weise S; Kropf S; Fry LC; Stahr A; Völkel S; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):150-8. PubMed ID: 19212204
[TBL] [Abstract][Full Text] [Related]
20. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
